Clinical Infectious Diseases · 2009 · 94 citations · 11 references
Veterinary MedicineDermatologyInfectious DiseasesClinical EpidemiologyInfectious Disease EpidemiologyParasite EpidemiologyIncidence StudiesParasitic Disease PathogenesisParasitic DiseasesParasitic PathologyProtozoal InfectionsSurveillance Of Parasitic DiseasesActive Case AscertainmentAnnual IncidenceAntileishmanial TreatmentLeishmaniasis Of The SkinLeishmaniasis PathogenesisLeishmaniasis PathologyPost-kala-azar Dermal LeishmaniasisVisceral Leishmaniasis
Post-kala-azar dermal leishmaniasis (PKDL) occurs after kala-azar treatment and acts as a durable infection reservoir. On the basis of active case finding among 22,699 respondents, 813 (3.6%) had had kala-azar since 2002, of whom 79 (9.7%) developed PKDL. Eight additional patients with PKDL had no history of kala-azar. Annual kala-azar incidence peaked at 85 cases per 10,000 person-years in 2004 and fell to 46 cases per 10,000 person-years in 2007, but PKDL incidence rose from 1 case per 10,000 person-years in 2002-2004 to 21 cases per 10,000 person-years in 2007. The rising PKDL incidence threatens the regional visceral leishmaniasis elimination initiative and underscores the urgent need for more effective PKDL diagnosis and treatment.
11
Richard A. Brown, Trevor Hastie, Robert Tibshirani · Biometrics · 1991 · 8.3K citations
Epidemiology of visceral leishmaniasis in India.
Durlav Prasad Bora · PubMed · 1999 · 234 citations
Risk Factors for Kala-Azar in Bangladesh
Caryn Bern, Allen W. Hightower, Rajib Chowdhury et al. · Emerging infectious diseases · 2005 · 222 citations · Full text
Veterinary Medicine, Community Health, Infectious Diseases +17
Israel Cruz, Carmen Cañavate, José Miguel Rubio et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 2002 · 210 citations